
Heidi L. Reese
Examiner (ID: 13855)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1657, 1625, 1622 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13835715
[patent_doc_number] => 20190021342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMPOSITIONS AND METHODS FOR PROVIDING PLANTS WITH TOLERANCE TO ABIOTIC STRESS CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/072137
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072137 | Compositions and methods for providing plants with tolerance to abiotic stress conditions | Jan 19, 2017 | Issued |
Array
(
[id] => 11618266
[patent_doc_number] => 20170128453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'NOVEL USES'
[patent_app_type] => utility
[patent_app_number] => 15/406346
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15528
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15406346
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/406346 | Uses | Jan 12, 2017 | Issued |
Array
(
[id] => 11948156
[patent_doc_number] => 20170252306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Pharmaceutical Compositions for Preventing and Treating Th1 or Th2 mediated Immune Disease Comprising 4H3MC(4-Hydroxy-3-methoxycinnamaldehyde) as an Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 15/397877
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8957
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397877 | Pharmaceutical Compositions for Preventing and Treating Th1 or Th2 mediated Immune Disease Comprising 4H3MC(4-Hydroxy-3-methoxycinnamaldehyde) as an Active Ingredient | Jan 3, 2017 | Abandoned |
Array
(
[id] => 12191617
[patent_doc_number] => 09895329
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-02-20
[patent_title] => 'Formyl peptide receptor 1 antagonists and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/393239
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6691
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393239 | Formyl peptide receptor 1 antagonists and uses thereof | Dec 27, 2016 | Issued |
Array
(
[id] => 12024960
[patent_doc_number] => 20170315059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'FLUORESCENT PROBES FOR MONITORING VOLTAGE BY PHOTO-INDUCED ELECTRON TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 15/391607
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23396
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391607 | Fluorescent probes for monitoring voltage by photo-induced electron transfer | Dec 26, 2016 | Issued |
Array
(
[id] => 14273563
[patent_doc_number] => 20190134066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => TREATMENT OF MODERATE TO SEVERE INFLUENZA
[patent_app_type] => utility
[patent_app_number] => 16/065600
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065600 | Treatment of moderate to severe influenza | Dec 21, 2016 | Issued |
Array
(
[id] => 16500051
[patent_doc_number] => 10865428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Method for producing organic acid
[patent_app_type] => utility
[patent_app_number] => 16/065638
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6891
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065638 | Method for producing organic acid | Dec 21, 2016 | Issued |
Array
(
[id] => 16267370
[patent_doc_number] => 20200268857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING HUNTER SYNDROME
[patent_app_type] => utility
[patent_app_number] => 16/066187
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066187 | Methods and compositions for treating hunter syndrome | Dec 20, 2016 | Issued |
Array
(
[id] => 16229320
[patent_doc_number] => 10736849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Method of lyophilization of a sample of faecal microbiota
[patent_app_type] => utility
[patent_app_number] => 16/063419
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7914
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063419 | Method of lyophilization of a sample of faecal microbiota | Dec 18, 2016 | Issued |
Array
(
[id] => 14762057
[patent_doc_number] => 10392413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
[patent_app_type] => utility
[patent_app_number] => 15/382872
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 94476
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382872 | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists | Dec 18, 2016 | Issued |
Array
(
[id] => 13942335
[patent_doc_number] => 10206912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Heteroaryl sulfonamides and CCR2/CCR9
[patent_app_type] => utility
[patent_app_number] => 15/383788
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 84926
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383788
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383788 | Heteroaryl sulfonamides and CCR2/CCR9 | Dec 18, 2016 | Issued |
Array
(
[id] => 11729265
[patent_doc_number] => 20170190709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'NOVEL COMPOSITIONS USEFUL IN TREATING BRAIN-RELATED DISEASES OR DISORDERS AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/382002
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 31500
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382002
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382002 | Compositions useful in treating brain-related diseases or disorders and methods using same | Dec 15, 2016 | Issued |
Array
(
[id] => 13778787
[patent_doc_number] => 20190002932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHOD FOR SYNTHESISING ORGANIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/063599
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063599 | Method for synthesising organic molecules | Dec 13, 2016 | Issued |
Array
(
[id] => 12023595
[patent_doc_number] => 20170313694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate'
[patent_app_type] => utility
[patent_app_number] => 15/375925
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12880
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/375925 | Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate | Dec 11, 2016 | Abandoned |
Array
(
[id] => 13117843
[patent_doc_number] => 10077264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Derivatives and methods of treating hepatitis B infections
[patent_app_type] => utility
[patent_app_number] => 15/375652
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40549
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/375652 | Derivatives and methods of treating hepatitis B infections | Dec 11, 2016 | Issued |
Array
(
[id] => 11929713
[patent_doc_number] => 09796698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Isoindoline compounds and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 15/376376
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48317
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15376376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/376376 | Isoindoline compounds and methods of their use | Dec 11, 2016 | Issued |
Array
(
[id] => 14102931
[patent_doc_number] => 20190093141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => BIOSYNTHESIS OF EVERNINOMICIN ANALOGS IN MICROMONOSPORA CARBONACEA VAR AURANTIACA
[patent_app_type] => utility
[patent_app_number] => 16/060467
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060467 | Biosynthesis of everninomicin analogs in | Dec 8, 2016 | Issued |
Array
(
[id] => 13622025
[patent_doc_number] => 20180362564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => CYCLIC PHOSPHATES AND CYCLIC PHOSPHORAMIDATES FOR THE TREATMENT OF NEUROLOGIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/060347
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 358
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060347 | Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders | Dec 7, 2016 | Issued |
Array
(
[id] => 13602515
[patent_doc_number] => 20180352806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => REDUCTION OF ERYTHROCYTE SEDIMENTATION RATE
[patent_app_type] => utility
[patent_app_number] => 15/780590
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780590 | Reduction of erythrocyte sedimentation rate | Dec 5, 2016 | Issued |
Array
(
[id] => 13607697
[patent_doc_number] => 20180355398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => METHOD OF ENUMERATING COLIFORM COLONIES
[patent_app_type] => utility
[patent_app_number] => 15/781547
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781547
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781547 | Method of enumerating coliform colonies | Dec 5, 2016 | Issued |